Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2335573
Max Phase: Preclinical
Molecular Formula: C20H17NO3
Molecular Weight: 319.36
Molecule Type: Small molecule
Associated Items:
ID: ALA2335573
Max Phase: Preclinical
Molecular Formula: C20H17NO3
Molecular Weight: 319.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(C#C/C=C\C#Cc2ccccn2)cc(OC)c1OC
Standard InChI: InChI=1S/C20H17NO3/c1-22-18-14-16(15-19(23-2)20(18)24-3)10-6-4-5-7-11-17-12-8-9-13-21-17/h4-5,8-9,12-15H,1-3H3/b5-4-
Standard InChI Key: UIWWQMNABCPXHB-PLNGDYQASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 319.36 | Molecular Weight (Monoisotopic): 319.1208 | AlogP: 3.07 | #Rotatable Bonds: 3 |
Polar Surface Area: 40.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.45 | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.82 | Np Likeness Score: -0.05 |
1. Lo YH, Lin YT, Liu YP, Duh TH, Lu PJ, Wu MJ.. (2013) Design, synthesis, biological evaluation and molecular modeling studies of 1-aryl-6-(3,4,5-trimethoxyphenyl)-3(Z)-hexen-1,5-diynes as a new class of potent antitumor agents., 62 [PMID:23419737] [10.1016/j.ejmech.2013.01.011] |
Source(1):